CONTACT US 0131 226 8200

Alexander Lamley

PartnerCorporate (UK and US)

Email: alexander.lamley@mbmcommercial.co.uk
Tel: 0131 226 8238

Alexander is a UK and US corporate lawyer, who advises businesses on mergers and acquisitions, equity and debt finance including early-stage investment by SAFEs, advance subscription agreements (ASAs) and other convertibles.

Alexander has assisted angel syndicates, VCTs and high net worth investors with advice on substantial investment into early-stage companies.  Alexander supports businesses from start-up, through investment and exit. He also regularly advises on share incentive schemes for early stage companies (EMI and unapproved options and growth shares). Alexander has assisted a number of UK clients expand or set up in the US including by "Delaware flip".

Personal Biography 

Alexander is a keen rock climber, musician and traveller. If he’s not at his desk, he can be found scaling a wall or crag somewhere nearby or standing in front of an amplifier.

 

Legal Experience

  • Advising multiple UK companies on ‘flipping’ into a new US corporation and receiving US investment;
  • Advising a data-log management company on receiving investment of $10m from a US VC;
  • Advising Rhizocore Technologies on receiving £3.5m investment from US and Australian VCs;
  • Advising Bioliberty on receiving £2.2m investment from Archangel, Eos and Old College Capital;
  • Advising Carcinotech on receiving £1.6m investment from Tricap, Eos, SIS Ventures and Scottish Enterprise;
  • Advising Wobble Genomics on its spin-out from University of Edinburgh and investment of £1.2m;
  • Advising Acu-flow on its spin-out from University of Glasgow and investment of £1.7m from Foresight Williams Technology and others;
  • Advising Tay Therapeutics on its spin-out from University of Dundee and investment of £1.6m pre-Series A funding;
  • Advising Mi:RNA on its spin-out from SRUC and seed investment;
  • Advising TenBio on its spin-out from University of Dundee and investment of £1m from Tricap;
  • Advising Wellfish Diagnostics on its spin-out from University West of Scotland and investment of £1.2m from Kelvin Capital and Scottish Enterprise;
  • Advising Lifesciences and green impact investor syndicate on its £2.5m investment into a green chemicals start up.

Contact us today